Cancer
Malignant Ovarian Neoplasm
CI-CAN-00003205Explore in graph →
Top-level685 active trials5 approved drugs83 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer
CI-CAN-00003205Explore in graph →
Clinical trials
3,087 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (437)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00132522 | EMD 273066 in Patients With Recurrent EpCAM Positive Ovarian, Prostate, Colorectal or Non-small Cell Lung Cancers When First Given Cyclophosphamide | completed | Phase 1 | 45 | EMD SeronoINDUSTRY | 2 | Oct 25, 2013 | clinicaltrials |
| NCT00721890 | Green Tea Intake for the Maintenance of Complete Remission in Women With Advanced Ovarian Carcinoma(DBGT-OC-CR) | completed | Phase 2 | 16 | CHU de Quebec-Universite LavalOTHER | 1 | Oct 24, 2013 |
| clinicaltrials |
| NCT00946140 | Motion Correction in Dynamic Contrast Enhanced Magnetic Resonance Imaging (MRI) in Ovarian Cancer: A Pilot Study | completed | — | 2 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Oct 24, 2013 | clinicaltrials |
| NCT00526149 | BI 2536 in Treating Patients With Recurrent or Metastatic Solid Tumors | completed | Phase 2 | 76 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 1 | Oct 7, 2013 | clinicaltrials |
| NCT00677079 | Single Arm Study of BSI-201 in Patients With BRCA-1 or BRCA-2 Associated Advanced Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer | completed | Phase 2 | 12 | SanofiINDUSTRY | 1 | Oct 1, 2013 | clinicaltrials |
| NCT00031681 | 7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007) | completed | Phase 1 | 41 | National Cancer Institute (NCI)NIH | 1 | Sep 30, 2013 | clinicaltrials |
| NCT00004921 | High-Dose Chemotherapy Compared With Standard Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer That Has Been Removed During Surgery | completed | Phase 3 | — | EBMT Solid Tumors Working PartyOTHER | 9 | Sep 17, 2013 | clinicaltrials |
| NCT00831636 | A Phase I/II Study of CP-4055 in Patients With Platinum Resistant Ovarian Cancer | completed | Phase 1 / Phase 2 | 28 | Clavis PharmaINDUSTRY | 2 | Sep 13, 2013 | clinicaltrials |
| NCT00711932 | The Effect of TRA-8 on Ovarian Cancer Tissue | completed | — | 478 | University of Alabama at BirminghamOTHER | 1 | Sep 11, 2013 | clinicaltrials |
| NCT00014456 | Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 35 | Dartmouth-Hitchcock Medical CenterOTHER | 1 | Aug 28, 2013 | clinicaltrials |
| NCT00263822 | Erlotinib or Observation in Treating Patients Who Have Undergone First-Line Chemotherapy for Ovarian Cancer, Peritoneal Cancer, or Fallopian Tube Cancer | completed | Phase 3 | 835 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 8 | Aug 27, 2013 | clinicaltrials |
| NCT00004876 | Carboplatin With or Without Thalidomide in Treating Patients With Ovarian Epithelial Cancer | completed | Phase 2 | 30 | Cancer Research UKOTHER | 1 | Aug 26, 2013 | clinicaltrials |
| NCT00006942 | Bryostatin 1 and Cisplatin in Treating Patients With Advanced Recurrent or Residual Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer | completed | Phase 2 | 32 | National Cancer Institute (NCI)NIH | 1 | Aug 26, 2013 | clinicaltrials |
| NCT00510653 | Gleevec Study for Patients With Ovarian Cancer | completed | Phase 2 | 73 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 23, 2013 | clinicaltrials |
| NCT00002538 | Laparoscopic Staging in Patients With Ovarian, Fallopian Tube, or Other Primary Abdominal Cancers | completed | Phase 2 | — | Gynecologic Oncology GroupNETWORK | 1 | Aug 20, 2013 | clinicaltrials |
| NCT00604994 | Prospective Evaluation of Lymphoedema Among Patients With Gynaecological Cancer(LEGS) | completed | — | 761 | Queensland Centre for Gynaecological CancerOTHER_GOV | 1 | Aug 20, 2013 | clinicaltrials |
| NCT00003732 | Combination Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Cancer | completed | Phase 2 | 80 | Rigshospitalet, DenmarkOTHER | 1 | Aug 12, 2013 | clinicaltrials |
| NCT00075712 | Timing of Surgery and Chemotherapy in Treating Patients With Newly Diagnosed Advanced Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer | completed | Phase 2 / Phase 3 | 150 | Royal College of Obstetricians and GynecologistsOTHER | 1 | Aug 12, 2013 | clinicaltrials |
| NCT00483782 | Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Newly Diagnosed Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer | completed | Phase 3 | 1,520 | Medical Research CouncilOTHER_GOV | 5 | Aug 12, 2013 | clinicaltrials |
| NCT00098878 | Carboplatin in Treating Patients With Stage IC-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer | completed | Phase 3 | 1,300 | NHS Greater Glasgow and ClydeOTHER | 3 | Aug 7, 2013 | clinicaltrials |
| NCT00005590 | Levofloxacin to Prevent Infection Following Chemotherapy in Treating Patients With Solid Tumors or Lymphoma | completed | Phase 3 | — | Cancer Research Campaign Clinical Trials CentreOTHER | 1 | Aug 2, 2013 | clinicaltrials |
| NCT00014690 | ZD9331 With or Without Topotecan in Treating Patients With Refractory or Recurrent Epithelial Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer | completed | Phase 2 | — | AstraZenecaINDUSTRY | 1 | Aug 2, 2013 | clinicaltrials |
| NCT01738269 | Elecsys HE4 Chinese Reference Value Study | completed | — | 2,351 | Chinese PLA General HospitalOTHER | 1 | Jul 31, 2013 | clinicaltrials |
| NCT00002568 | Combination Chemotherapy With or Without Surgery in Treating Patients With Stage III Ovarian Epithelial Cancer | completed | Phase 3 | 470 | Gynecologic Oncology GroupNETWORK | 1 | Jul 9, 2013 | clinicaltrials |
| NCT00006235 | Liposomal Doxorubicin and Carboplatin in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer | completed | Phase 1 | — | Gynecologic Oncology GroupNETWORK | 0 | Jul 9, 2013 | clinicaltrials |
| NCT00003811 | Combination Chemotherapy Plus Amifostine in Treating Children With Malignant Germ Cell Tumors | completed | Phase 2 | 27 | Children's Oncology GroupNETWORK | 6 | Jul 4, 2013 | clinicaltrials |
| NCT00003103 | Chemotherapy in Treating Patients With Solid Tumors | completed | Phase 1 / Phase 2 | 57 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jul 3, 2013 | clinicaltrials |
| NCT00002559 | Combination Chemotherapy in Treating Patients With Germ Cell Tumors That Have Not Responded to Previous Cisplatin | completed | Phase 1 / Phase 2 | 43 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jul 2, 2013 | clinicaltrials |
| NCT00002489 | Combination Chemotherapy in Treating Children With Non-testicular Malignant Germ Cell Tumors | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 26, 2013 | clinicaltrials |
| NCT00002928 | Paclitaxel in Treating Patients With Recurrent or Progressive Advanced Ovarian Cancer | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 26, 2013 | clinicaltrials |
| NCT00004008 | Bryostatin 1 in Treating Patients With Ovarian Epithelial Cancer | completed | Phase 2 | — | University of GlasgowOTHER | 1 | Jun 26, 2013 | clinicaltrials |
| NCT00004082 | Combination Chemotherapy in Treating Patients With Previously Untreated, Newly Diagnosed Epithelial Tumors | completed | Phase 1 | — | Beth Israel Deaconess Medical CenterOTHER | 1 | Jun 26, 2013 | clinicaltrials |
| NCT00022347 | TLK286 in Treating Patients With Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 26, 2013 | clinicaltrials |
| NCT00055614 | Topotecan in Treating Patients With Advanced Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer | completed | Phase 1 | 20 | Beth Israel Deaconess Medical CenterOTHER | 1 | Jun 26, 2013 | clinicaltrials |
| NCT00138242 | Docetaxel and Carboplatin in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer | completed | Phase 2 | 30 | Floyd & Delores Jones Cancer Institute at Virginia Mason Medical CenterOTHER | 1 | Jun 26, 2013 | clinicaltrials |
| NCT00002515 | Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Rare Cancer | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 24, 2013 | clinicaltrials |
| NCT00004012 | Capecitabine in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 24, 2013 | clinicaltrials |
| NCT00004065 | Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic Cancer | completed | Phase 1 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 24, 2013 | clinicaltrials |
| NCT00023699 | Gefitinib in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer or Primary Peritoneal Cancer | completed | Phase 2 | — | Gynecologic Oncology GroupNETWORK | 4 | Jun 24, 2013 | clinicaltrials |
| NCT00070096 | Ixabepilone in Treating Patients With Advanced Cisplatin-Refractory Germ Cell Tumors | completed | Phase 2 | 29 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 24, 2013 | clinicaltrials |
| NCT00003345 | Cisplatin Plus Irinotecan in Treating Patients With Ovarian, Fallopian Tube, or Peritoneal Cancer | completed | Phase 2 | 35 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 21, 2013 | clinicaltrials |
| NCT00003523 | Aminocamptothecin in Treating Patients With Recurrent or Refractory Ovarian Epithelial Cancer or Primary Cancer of the Peritoneum | completed | Phase 2 | — | Gynecologic Oncology GroupNETWORK | 2 | Jun 21, 2013 | clinicaltrials |
| NCT00005836 | Oxaliplatin in Treating Patients With Recurrent or Refractory Ovarian Epithelial Cancer or Primary Peritoneal Cancer That Has Not Responded to Platinum- Based Chemotherapy | completed | Phase 2 | — | Gynecologic Oncology GroupNETWORK | 2 | Jun 21, 2013 | clinicaltrials |
| NCT00005952 | Temozolomide Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Malignant Glioma or Recurrent CNS or Other Solid Tumors | completed | Phase 1 / Phase 2 | 30 | Duke UniversityOTHER | 1 | Jun 20, 2013 | clinicaltrials |
| NCT00019084 | Vaccine Therapy and Biological Therapy in Treating Patients With Advanced Cancer | completed | Phase 2 | — | National Cancer Institute (NCI)NIH | 1 | Jun 20, 2013 | clinicaltrials |
| NCT00019461 | Carboxyamidotriazole in Treating Patients With Refractory or Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer | completed | Phase 2 | — | National Cancer Institute (NCI)NIH | 1 | Jun 20, 2013 | clinicaltrials |
| NCT00019552 | Irofulven in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, or Peritoneal Cancer | completed | Phase 2 | — | National Cancer Institute (NCI)NIH | 1 | Jun 20, 2013 | clinicaltrials |
| NCT00019916 | Vaccine Therapy Plus Interleukin-2 in Treating Women With Stage IV, Recurrent, or Progressive Breast or Ovarian Cancer | completed | Phase 1 / Phase 2 | — | National Cancer Institute (NCI)NIH | 1 | Jun 20, 2013 | clinicaltrials |
| NCT00049556 | Gefitinib in Treating Patients With Cervical Cancer | completed | Phase 2 | — | National Cancer Institute (NCI)NIH | 1 | Jun 20, 2013 | clinicaltrials |
| NCT00006041 | Vaccine Therapy in Treating Patients With Ovarian, Fallopian Tube, or Peritoneal Cancer | completed | Phase 1 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 19, 2013 | clinicaltrials |
Data updated 23 days agoSource updated Oct 25, 2013source: clinicaltrials